The collaboration is anchored in Syngene’s SynVent platform and Connector model to accelerate promising academic research
The agreement is for the development and commercialisation of JHU’s novel target and technology that will help patients with colorectal cancer
At launch of updated pediatric gastroenterology textbook, Union Minister says technology must strengthen not substitute core medical learning
Salanersen was generally well-tolerated, slowed neurodegeneration, and enabled functional gains
The study showed a 76% complete response (CR) rate at 12 months, rising to 95% at any time for high-risk NMIBC patients
Over a two-decade career, Dr. Berman has worked on more than a dozen clinical-stage immunotherapies, including senior leadership roles in developing four oncology biologics
Developed in partnership with the Johns Hopkins Applied Physics Laboratory (APL), the module is built around a multi-segment RT-PCR method with integrated indexing
Building on the Merck Foundation’s longstanding commitment to advancing access to high-quality health care, new national initiative supports grants to 11 organizations across the country
Phase 3 program for NDV-01 in non-muscle invasive bladder cancer expected to begin in the first half of 2026
This case report is jointly authored by US clinicians from leading hospitals, Houston Methodist Hospital, Weill Cornell Medical College and Johns Hopkins
Subscribe To Our Newsletter & Stay Updated
